Incorporating Research Into Sight (IRIS) Essentia Rural Health Institute Marshfield Clinic Penn State University

Major US Genomic Medicine Programs: NHGRI s Electronic Medical Records and Genomics (emerge) Network

Major US Genomic Medicine Programs: NHGRI s Electronic Medical Records and Genomics (emerge) Network Dan Roden Member, National Advisory Council For Human Genome Research Genomic Medicine Working Group

Technical Issues in Aggregating and Analyzing Data from Heterogeneous EHR Systems

Technical Issues in Aggregating and Analyzing Data from Heterogeneous EHR Systems Josh Denny, MD, MS josh.denny@vanderbilt.edu Vanderbilt University, Nashville, Tennessee, USA 2/12/2015 EHR data are dense

Potentials for EHR Phenotyping in SJS/TEN

Potentials for EHR Phenotyping in SJS/TEN Josh Denny, MD, MS josh.denny@vanderbilt.edu Vanderbilt University, Nashville, Tennessee, USA 3/3/2015 emerge goals To perform GWAS using EMR-derived phenotypes

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate

EHRs and large scale comparative effectiveness research

EHRs and large scale comparative effectiveness research September 16, 2014 Dana C. Crawford, PhD Associate Professor Epidemiology and Biostatistics Institute for Computational Biology Single Nucleotide

Outcome Data, Links to Electronic Medical Records. Dan Roden Vanderbilt University

Outcome Data, Links to Electronic Medical Records Dan Roden Vanderbilt University Coordinating Center Type II Diabetes Case Algorithm * Abnormal lab= Random glucose > 200mg/dl, Fasting glucose > 125 mg/dl,

Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider

Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider Daniel Masys, M.D. Affiliate Professor Biomedical and Health Informatics University of Washington, Seattle

Radiology Business Management Association Technology Task Force. Sample Request for Proposal

Technology Task Force Sample Request for Proposal This document has been created by the RBMA s Technology Task Force as a guideline for use by RBMA members working with potential suppliers of Electronic

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014 The chart below lists the measures (and specialty exclusions) that eligible providers must

EMR Systems and the Conduct of Clinical Research. Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine

EMR Systems and the Conduct of Clinical Research Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Clinical Research Environment Research protocols are becoming

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly

Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future

Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future Daniel Masys, MD Professor and Chair Department of Biomedical Informatics Professor of Medicine Vanderbilt

Introduction to genetic testing and pharmacogenomics

Introduction to genetic testing and pharmacogenomics Cecile Janssens Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands (a.janssens@erasmusmc.nl) Genetic prediction of monogenic diseases

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources James Floyd, MD, MS Sep 17, 2015 UW Hospital Medicine Faculty Development Program Objectives Become more

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015 The chart below lists the measures (and specialty exclusions) that eligible providers must

Age-related macular degeneration

Winter/Spring 2015 Volume 10, Number 1 PersonalizedMedicine Research Project Vitreous gel Cornea Pupil Lens Retina Macula Optic Nerve The human eye Age-related macular degeneration Inside From the Director,

Canadian National Institute for the Blind (CNIB)

Canadian National Institute for the Blind (CNIB) Agency Name and Contact Information Canadian National Institute for the Blind (CNIB): The mission of CNIB is to enhance independence for Canadians who are

2012 Physician Quality Reporting System:

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services R Official CMS Information for Medicare Fee-For-Service Providers 2012 Physician Quality : Medicare Electronic Health Record

Patient Intake Form. Patient Information. How did you find out about our office?

Atlanta Injury and Wellness Center 2740 Greenbriar Parkway Suite A 3 Atlanta, GA 30331 404 629 9999 Patient Intake Form Welcome to our office of chiropractic. Thank you for taking a moment to fill in our

A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm

A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm Zi Ye, 1 MD, Erin Austin, 1,2 PhD, Daniel J Schaid, 2 PhD, Iftikhar J. Kullo, 1 MD Affiliations: 1 Division of Cardiovascular Diseases and

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012

Psychiatrists and Reporting on Meaningful Use Stage 1 August 6, 2012 Quick Overview Functional Measures Providers (tracked by NPI) must report on 15 core objectives and associated measures and 5 objectives

SOUTH PALM CARDIOVASCULAR ASSOCIATES, INC. CHARLES L. HARRING, M.D. NEW PATIENT INFORMATION FORM. Patient Name: Home Address:

NEW PATIENT INFORMATION FORM Today s Date: Referred by: Patient Name: (First) (Last) Date of Birth: Gender: M / F SSN: Home Address: Home Phone (Area Code & No.): ( ) - Cell Phone: ( ) - Secondary Address

The Eyes Have It! by Carol A. Rice, Ph.D., R.N. Professor and Extension Health Specialist. Fall, 2001

The Eyes Have It! by Carol A. Rice, Ph.D., R.N. Professor and Extension Health Specialist Fall, 2001 Educational programs of the Texas A&M AgriLife Extension Service are open to all people without regard

Lake Oswego Eye Clinic 530 First ST, Suite A Lake Oswego, OR 97068 Office: (503) 636-9608 Fax: (503) 636-9600

PAYMENT AGREEMENT: We accept most insurance plans as a courtesy. We encourage you to familiarize yourself with your individual plan. Insurance coverage is an agreement between patient and insurance company

Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition

Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmologists can register for the Medicare electronic health record (EHR) incentive program on the CMS website: https://ehrincentives.cms.gov

Enhancing Functionality of EHRs for Genomic Research, Including E- Phenotying, Integrating Genomic Data, Transportable CDS, Privacy Threats

Enhancing Functionality of EHRs for Genomic Research, Including E- Phenotying, Integrating Genomic Data, Transportable CDS, Privacy Threats Genomic Medicine 8 meeting Alexa McCray Christopher G Chute Rex

Genomic Testing: Actionability, Validation, and Standard of Lab Reports

Genomic Testing: Actionability, Validation, and Standard of Lab Reports emerge: Laura Rasmussen-Torvik Reaction: Heidi Rehm Summary: Dick Weinshilboum Panel: Murray Brilliant, David Carey, John Carpten,

TALLAHASSEE EYE CENTER

TALLAHASSEE EYE CENTER PATIENT INFORMATION Date: Name: Gender: M / F First MI Last Date of Birth: / / Address: City: State: ZIP: Phone Numbers: Home: Cellular: Work: E-Mail: SS#: - - What is the best way

Family History and Diabetes. Practical Genomics for the Public Health Professional

Family History and Diabetes Practical Genomics for the Public Health Professional Outline Overview of Type 2 Diabetes/Gestational Diabetes Familial/Genetic Nature of Diabetes Interaction of Genes and Environment

PROMISE & PITFALLS OF OUTCOMES RESEARCH USING EMR DATABASES. Richard L. Tannen, M.D., Mark Weiner, Dawei Xie

PROMISE & PITFALLS OF OUTCOMES RESEARCH USING EMR DATABASES Richard L. Tannen, M.D., Mark Weiner, Dawei Xie GOALS OF STUDY Determine Whether Studies Using EMR Database Yield Valid Outcome Assessment Major

Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects

Report on the Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects Background and Goals of the Workshop June 5 6, 2012 The use of genome sequencing in human research is growing

RHODE ISLAND SERVICES FOR THE BLIND AND VISUALLY IMPAIRED ORS/DHS THE INDEPENDENT LIVING FOR OLDER BLIND PROGRAM

RHODE ISLAND SERVICES FOR THE BLIND AND VISUALLY IMPAIRED ORS/DHS THE INDEPENDENT LIVING FOR OLDER BLIND PROGRAM FINAL EVALUATION REPORT OCTOBER 1, 2005 - SEPTEMBER 30, 2006 Prepared by Kristine L. Chadwick,

Reduced Risk & Improved Efficacy through Integrated Pharmacogenetics

August 13, 2014 Reduced Risk & Improved Efficacy through Integrated Pharmacogenetics Allscripts Client Experience 2014 1 Reduced Risk & Improved Efficacy through Integrated Pharmacogenetic Analysis Stone

Thank you for making an appointment with our office. We look forward to serving your visual needs.

Dear New Patient, Thank you for making an appointment with our office. We look forward to serving your visual needs. Enclosed you will find our New Patient Questionnaires. Please complete these and fax

CFAR Network of Integrated Clinical Systems(CNICS): The Use of Real-Time, Patient-Centered, Clinical Metrics

The Intersection of Technology, HAART Adherence, and Drug Abuse Treatment CFAR Network of Integrated Clinical Systems(CNICS): The Use of Real-Time, Patient-Centered, Clinical Metrics Stephen L. Boswell,

Participating in Alzheimer s Disease Clinical Trials and Studies

Participating in Alzheimer s Disease Clinical Trials and Studies FACT SHEET When Margaret was diagnosed with earlystage Alzheimer s disease at age 68, she wanted to do everything possible to combat the

MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives EPs must meet 3 of the 6 menu measures.

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene

Stage 1 Meaningful Use for Specialists NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene 1 Today s Agenda Meaningful Use Overview Meaningful Use Measures Resources Primary

You ve Been Dealt. You ve Been Dealt. You ve Been Dealt. You ve Been Dealt. You ve Been Dealt. You ve Been Dealt. You ve Been Dealt.

Sexual Dysfunction Emphysema Osteoporosis Arthritis Memory Loss Alzheimer s Disease Sensory Loss Loss of Balance Lower BMR Stroke Gout Loss of Hair Loss of Muscle Mass Diabetes Shingles COPD Gray Hair

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary 2010 What are the Requirements of Stage 1 Meaningful Use? Basic Overview of Stage 1 Meaningful Use: Reporting period

Enrollment Application for Medicare Supplement

Group Health Options, Inc. PO Box 34803 Seattle, WA 98124-1803 PLAN CHOICE rplan A rplan F rplan K rplan N Enrollment Application for Medicare Supplement PLEASE PRINT Answer all questions completely and

Enrollment Application for Medicare Supplement

Page 1 of 6 PO Box 34803 Seattle, WA 98124-1803 SECTION 1 PLAN CHOICE rplan A (2010 STANDARDIZED) rplan F (2010 STANDARDIZED) rplan K rplan N PLEASE PRINT Answer all questions completely and accurately

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

Meaningful Use Medicare and Medicaid Table of Contents What is Meaningful Use?... 1 Table 1: Patient Benefits... 2 What is an EP?... 4 How are Registration and Attestation Being Handled?... 5 What are

Electronic Phenotyping and Genomic Research

National Human Genome Research Institute Electronic Phenotyping and Genomic Research National Institutes of Health U.S. Department of Health and Human Services National Institutes of Health National Human

MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY On August 24, the Centers for Medicare & Medicaid Services (CMS) posted the much anticipated final rule for Stage

Big Data for Population Health

Big Data for Population Health Prof Martin Landray Nuffield Department of Population Health Deputy Director, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery University of Oxford

Using EHRs for Heart Failure Therapy Recommendation Using Multidimensional Patient Similarity Analytics

Digital Healthcare Empowering Europeans R. Cornet et al. (Eds.) 2015 European Federation for Medical Informatics (EFMI). This article is published online with Open Access by IOS Press and distributed under

GENETICS AND GENOMICS IN NURSING PRACTICE SURVEY

GENETICS AND GENOMICS IN NURSING PRACTICE SURVEY Dear Registered Nurse: You are invited to take a survey that will evaluate primary issues in genetics and genomics. As the front line of care, nurses have

Get Your Eyes Examined

1 Vision Changes You may notice vision changes with aging. Many changes are common and can often be corrected. As you get older, you are at higher risk of age-related eye diseases and conditions. Get Your

Ophthalmology Meaningful Use Attestation Guide Stage 2 2014 Edition

Ophthalmology Meaningful Use Attestation Guide Stage 2 2014 Edition Physicians who first participated in meaningful use in 2011 or 2012 must move on to Stage 2 in 2014. For 2014 only, physicians will attest

Technology Using Electronic Health Records to Improve the

Health Information Law and Technology Using Electronic Health Records to Improve the Public s Health David C Kaelber, MD, PhD, MPH, FAAP, FACP Internal Medicine and Pediatrics Physician Chief Medical Informatics

EMR Systems and the Conduct of Clinical Research. Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine

EMR Systems and the Conduct of Clinical Research Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Clinical Research Environment Research protocols are becoming

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

Manitoba EMR Data Extract Specifications

MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the

Mark Anderson, FHIMSS, CPHIMSS Healthcare IT Futurist. Presented By Our Featured Speaker Mark R. Anderson, FHIMSS, CPHIMS CEO, AC Group

DRT enabled EHRs Presented By Our Featured Speaker Mark R. Anderson, FHIMSS, CPHIMS CEO, AC Group Mark Anderson, FHIMSS, CPHIMSS Healthcare IT Futurist CEO of AC Group Conducted > 300 Technology Software

Quality in Patient Care Know It, Use It, Prove It, Oh My! Disclosures 5/18/2015. Jeff Michaels, OD, FAAO Andrew Archila, OD, FAAO

Quality in Patient Care Know It, Use It, Prove It, Oh My! Jeff Michaels, OD, FAAO Andrew Archila, OD, FAAO Disclosures Dr. Michaels and Dr. Archila hold zero financial benefit to the products contained

AFib (short for atrial fibrillation) is the most common type of irregular heartbeat, affecting literally millions of men and women

What is atrial fibrillation? AFib (short for atrial fibrillation) is the most common type of irregular heartbeat, affecting literally millions of men and women What is atrial fibrillation? AFib occurs

Assessing the Accuracy of the Technology-based Eye Care Services (TECS) Protocol to a Standard Clinical Ophthalmic Exam

Assessing the Accuracy of the Technology-based Eye Care Services (TECS) Protocol to a Standard Clinical Ophthalmic Exam Introduction: As patients age, they are more at risk to lose vision. Routine eye

NGS and complex genetics

NGS and complex genetics Robert Kraaij Genetic Laboratory Department of Internal Medicine r.kraaij@erasmusmc.nl Gene Hunting Rotterdam Study and GWAS Next Generation Sequencing Gene Hunting Mendelian gene

Age-Related Eye Diseases and Conditions. See Well for a Lifetime

Age-Related Eye Diseases and Conditions See Well for a Lifetime Vision Changes You may notice vision changes with aging. Many changes are common and can often be corrected. As you get older, you are at

CARDIOVASCULAR PROBLEMS IN SURVIVORS OF CHILDHOOD CANCER AND THEIR SIBLINGS

Swiss Childhood Cancer Registry (SCCR) CARDIOVASCULAR PROBLEMS IN SURVIVORS OF CHILDHOOD CANCER AND THEIR SIBLINGS Julien Caccia, Corina S. Rueegg, Eva-Maria Hau, Nicolas X. von der Weid, Gisela Michel,

The M.U.R.D.O.C.K. Study

1 The M.U.R.D.O.C.K. Study Measurement to Understand Reclassification of Disease Of Cabarrus/Kannapolis Jessica Tenenbaum, PhD and many, many others 2 MURDOCK Study Measurement to Understand the Reclassification

Client Information for Informed Consent TESTOSTERONE FOR TRANSGENDER PATIENTS

Client Information for Informed Consent TESTOSTERONE FOR TRANSGENDER PATIENTS You want to take testosterone to masculinize your body. Before taking it, there are several things you need to know about.

Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES

DATABASE REVIEW Grampian University Hospitals NHS Trust GRAMPIAN DIABETES SERVICES DATABASE Page 1 Contents Contents 2 Introduction 3 History 3 Overview of Database 3 Database Structure 4 Main Table Summary

REGISTRATION FORM PATIENT NAME: ADDRESS (STREET, CITY, STATE, ZIP): HOME PHONE: WORK PHONE: CELL PHONE: DATE OF BIRTH: / / AGE: SEX:

REGISTRATION FORM PATIENT NAME: ADDRESS (STREET, CITY, STATE, ZIP): HOME PHONE: WORK PHONE: CELL PHONE: E-MAIL ADDRESS: OCCUPATION: DATE OF BIRTH: / / AGE: SEX: SOCIAL SECURITY NUMBER: MARITAL STATUS:

Medical Fitness. Annual Meeting December 2012. By: Deb Riggs, MEd, General Manager

Exercise is Medicine Referral Process Utilizing an EMR Medical Fitness Association Annual Meeting December 2012 By: Deb Riggs, MEd, General Manager Faculty Disclosure Deb Riggs Deb Riggs has listed no

Stage 1 measures. The EP/eligible hospital has enabled this functionality

EMR Name/Model Ingenix CareTracker - version 7 EMR Vendor Ingenix CareTracker Stage 1 objectives Use CPOE Use of CPOE for orders (any type) directly entered by authorizing provider (for example, MD, DO,

Dear Patient, We look forward to seeing you.

Dear Patient, Welcome to Mosier Eye Center! We appreciate your selection of our office and we look forward to serving you for all your eye care needs. This packet was created to provide you with some valuable

PATIENT INFORMATION FORM. Name: Address: City: State: Zip: Social Security Number: Telephone Numbers Home: Age: Sex: M / F Work: Email: Cell:

PATIENT INFORMATION FORM Name: Address: City: State: Zip: Social Security Number: Telephone Numbers DOB: Home: Age: Sex: M / F Work: Email: Cell: Marital Status: Single Married Spouse s Name: Widowed Divorced

The Contribution of large Healthcare Systems to Improving Treatment for Patients with Rare Diseases

Uniting Rare Diseases Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories and Clinical Data Keynote address: The Contribution of large Healthcare Systems to

Thank you for your interest in the KPS Health Plans Medicare Supplement plan!

Thank you for your interest in the KPS Health Plans Medicare Supplement plan! Below is a link to the policy outline and attached is a printable copy of the Medicare Supplement Enrollment Form. Should you

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

Big Data for Population Health and Personalised Medicine through EMR Linkages

Big Data for Population Health and Personalised Medicine through EMR Linkages Zheng-Ming CHEN Professor of Epidemiology Nuffield Dept. of Population Health, University of Oxford Big Data for Health Policy

ASSESSMENT OF THE OLDER ADULT

ASSESSMENT OF THE OLDER ADULT OBJECTIVES Know and understand: How to assess the functional ability of the older adult Why a focus on function is important How to perform a comprehensive geriatric assessment

Extraction of Pharmacogenomics Traits from Electronic Health Records

Extraction of Pharmacogenomics Traits from Electronic Health Records Assistant Professor Institute for Computational Biology Department of Epidemiology and Biostatistics Case Western Reserve University

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

Practice Readiness Assessment

Practice Demographics Practice Name: Tax ID Number: Practice Address: REC Implementation Agent: Practice Telephone Number: Practice Fax Number: Lead Physician: Project Primary Contact: Lead Physician Email

Bench to Bedside Clinical Decision Support:

Bench to Bedside Clinical Decision Support: The Role of Semantic Web Technologies in Clinical and Translational Medicine Tonya Hongsermeier, MD, MBA Corporate Manager, Clinical Knowledge Management and

Jamie Dow MBA MD Émilie Turmel BSc Société de l assurance automobile du Québec NMEDA, Quebec 23 septembre 2010 23 septembre 2010 7323 35 (2008-09) Société de l'assurance automobile du Québec, 2010 Page

General Medical Questionnaire

JONATHAN S LYONS MD, THOMAS H YAU MD, LLC ROBERT P FRIEDLAENDER MD ARUSHA GUPTA MD EYE PHYSICIANS AND SURGEONS 8630 Fenton Street, Suite 514 Silver Spring MD 20910 PATIENT INFORMATION FORM (PLEASE CIRCLE)

Ophthalmic Innovation 2015 A View from the AAO

Ophthalmic Innovation 215 A View from the AAO Ophthalmic Innovation 215: a view from the AAO IRIS David W. Parke II, MD CEO American Academy of Ophthalmology Introduction to AAO s IRIS Registry IRIS Registry

Virginia Women s Health Stroke Prevention Initiative

Virginia Women s Health Stroke Prevention Initiative Table of Contents Main Section of the Proposal. 3-12 Overall Aim & Objectives. Current Assessment of Need in Target Area Technical Approach, Intervention

GENETICS AND INSURANCE: QUANTIFYING THE IMPACT OF GENETIC INFORMATION

GENETICS AND INSURANCE: QUANTIFYING THE IMPACT OF GENETIC INFORMATION Angus Macdonald Department of Actuarial Mathematics and Statistics and the Maxwell Institute for Mathematical Sciences Heriot-Watt

Rx Updates New Guidelines, New Medications What You Need to Know

Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact

The Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins

The Future of the Electronic Health Record Gerry Higgins, Ph.D., Johns Hopkins Topics to be covered Near Term Opportunities: Commercial, Usability, Unification of different applications. OMICS : The patient

2005 Survey of Public Knowledge, Attitudes, and Practices Related to Eye Health and Disease. Executive Summary

2005 Survey of Public Knowledge, Attitudes, and Practices Related to Eye Health and Disease Executive Summary March 2008 EXECUTIVE S U M M A R Y Eye diseases, which include diabetic retinopathy, glaucoma,

White Paper. Ophthalmology Site Certification

White Paper Ophthalmology Site Certification Table of Contents 1. Introduction... 3 2. What is Site Certification?... 3 3. An Example of Certification for Ophthalmology Studies... 3 4. Visual Acuity Certification...

GENETICS AND HEALTH INSURANCE

GENETICS AND HEALTH INSURANCE Angus Macdonald Department of Actuarial Mathematics and Statistics and the Maxwell Institute for Mathematical Sciences Heriot-Watt University, Edinburgh www.maxwell.ac.uk

Electronic Health Record (EHR) Data Analysis Capabilities

Electronic Health Record (EHR) Data Analysis Capabilities January 2014 Boston Strategic Partners, Inc. 4 Wellington St. Suite 3 Boston, MA 02118 www.bostonsp.com Boston Strategic Partners is uniquely positioned

Stroke Prevention In Atrial Fibrillation Integrated Care Clinics Patient Reported Outcome Measures

Stroke Prevention In Atrial Fibrillation Integrated Care Clinics Patient Reported Outcome Measures Apodi Healthcare Mathew s Practice, Sheffield. June & July 2013 This SPAF Integrated Care Clinic programme

Implementation of Pharmacogenomics in Clinical Practice: Barriers and Potential Solutions

Molecular Pathology : Principles in Clinical Practice Implementation of Pharmacogenomics in Clinical Practice: Barriers and Potential Solutions KT Jerry Yeo, Ph.D. University of Chicago Email: jyeo@bsd.uchicago.edu

CALCAGNO AND ROSSI VEIN TREATMENT CENTER PATIENT INFORMATION SHEET. Last First Middle Name: Name: Initial: Male: Address: City: State: Zip:

CALCAGNO AND ROSSI VEIN TREATMENT CENTER PATIENT INFORMATION SHEET Last First Middle Initial: Male: Is this your legal name? Female: Yes / no If not, what is your legal name: Address: City: State: Zip:

Personal Contact and Insurance Information

Kenneth A. Holt, M.D. 3320 Executive Drive Tele: 919-877-1100 Building E, Suite 222 Fax: 919-877-8118 Raleigh, NC 27609 Personal Contact and Insurance Information Please fill out this form as completely

ABSTRACT INTRODUCTION STUDY DESCRIPTION

ABSTRACT Paper 1675-2014 Validating Self-Reported Survey Measures Using SAS Sarah A. Lyons MS, Kimberly A. Kaphingst ScD, Melody S. Goodman PhD Washington University School of Medicine Researchers often

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS Executive Summary Chronic Obstructive Pulmonary Disease (COPD) is a common chronic

Form ### Transgender Hormone Therapy - Estrogen Informed Consent SAMPLE

What are the different medications that can help to feminize me? Estrogen - Different types of the hormone estrogen can help you appear more feminine. Estrogen is the female sex hormone. Androgen blocker

The VITamin D and OmegA-3 TriaL (VITAL)

The VITamin D and OmegA-3 TriaL (VITAL) JoAnn E. Manson, MD, DrPH Principal Investigator, VITAL Brigham and Women's Hospital Professor of Medicine and the Michael and Lee Bell Professor of Women s Health